Get the Daily Brief
Latest Biotech News
Alzheimer’s and Neurodegenerative Disease Advances
Multiple studies illuminate neurodegenerative disease mechanisms and diagnosis. Dr. Sophia Shi detailed how sugar molecule degradation in the brain’s glycocalyx contributes to aging and...
Innovations in Bioprinting and Tissue Engineering Materials
Researchers at Stony Brook University developed TRACE (Tunable Rapid Assembly of Collagenous Elements), a novel collagen bioprinting method enabling instant assembly of physiological collagen...
Breakthroughs in Cancer Diagnostics and Therapeutics
Recent studies advance cancer care with novel diagnostic and therapeutic approaches. Indiana University secured FDA clearance for the first blood test detecting Alzheimer’s amyloid pathology,...
AI Advances Enhance Drug Discovery and Genetic Insights
Biotech and academic researchers harness artificial intelligence to unravel genetic networks and streamline drug discovery. Northwestern University developed TWAVE, an AI tool identifying gene...
Metsera's Amylin Analogue Shows Promise for Obesity Treatment
Metsera Inc. released early clinical data indicating their long-acting amylin analogue, MET-233i, induces significant dose-dependent weight loss with an extended half-life supporting once-monthly...
Oral PCSK9 Inhibitors Demonstrate Efficacy in Late-Stage Trials
Merck & Co. reported positive results from two Phase III trials of their oral PCSK9 inhibitor enlicitide decanoate, achieving statistically significant reductions in LDL cholesterol in patients...
FDA Approves Competing RSV Antibody Drugs Amid Advisory Committee Overhaul
Merck's RSV antibody drug Enflonsia has received FDA approval for infants under 12 months, entering a market dominated by Sanofi and AstraZeneca's Beyfortus. This approval coincides with the...